Bellevue Group Ag Zoetis Inc. Transaction History

Bellevue Group Ag

$5.02 Billion
Q4 2024

A detailed history of Bellevue Group Ag transactions in Zoetis Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 9,779 shares of ZTS stock, worth $1.54 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,779

Previous 5,284 85.07%

Holding current value

$1.54 Million

Previous $1.03 Million 54.36%

% of portfolio

0.03%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$162.24 - $194.42 $729,268 - $873,917	4,495 Added 85.07%	9,779 $1.59 Million
Q3 2024 Nov 14, 2024	BUY	$172.58 - $196.48 $404,354 - $460,352	2,343 Added 79.67%	5,284 $1.03 Million
Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $664,972 - $817,074	-4,569 Reduced 60.84%	2,941 $509,000
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $284,952 - $343,896	1,720 Added 29.71%	7,510 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $101,767 - $134,460	-672 Reduced 10.4%	5,790 $1.14 Million
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $5,682 - $6,554	-34 Reduced 0.52%	6,462 $1.12 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $824,495 - $954,056	5,123 Added 373.12%	6,496 $1.12 Million
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $199,744 - $240,302	1,373 New	1,373 $228,000
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $38,110 - $46,915	-257 Reduced 51.09%	246 $36,000
Q2 2022 Aug 11, 2022	BUY	$155.97 - $200.09 $78,452 - $100,645	503 New	503 $86,000
Q1 2022 May 13, 2022	SELL	$181.39 - $234.03 $1.29 Million - $1.66 Million	-7,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $1.11 Million - $1.33 Million	7,100 New	7,100 $1.32 Million

Others Institutions Holding ZTS

# of Institutions

2,031

Shares Held

416M

Call Options Held

1.23M

Put Options Held

1.3M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $73.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Zoetis Inc. Transaction History